A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban

MLA

Frost C, et al. “A Randomized Direct Comparison of the Pharmacokinetics and Pharmacodynamics of Apixaban and Rivaroxaban.” Clinical Pharmacology: Advances and Applications, vol. 2014, no. default, Nov. 2014, pp. 179–87. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.17193646f7134bbe8f4f813d423d9e13&authtype=sso&custid=ns315887.

APA

Frost C, Song Y, Barrett YC, Wang J, Pursley J, Boyd RA, & LaCreta F. (2014). A randomized direct comparison of the pharmacokinetics and pharmacodynamics of apixaban and rivaroxaban. Clinical Pharmacology: Advances and Applications, 2014(default), 179–187.

Chicago

Frost C, Song Y, Barrett YC, Wang J, Pursley J, Boyd RA, and LaCreta F. 2014. “A Randomized Direct Comparison of the Pharmacokinetics and Pharmacodynamics of Apixaban and Rivaroxaban.” Clinical Pharmacology: Advances and Applications 2014 (default): 179–87. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsdoj&AN=edsdoj.17193646f7134bbe8f4f813d423d9e13&authtype=sso&custid=ns315887.